WuXi AppTec’s recent disclosure highlighted increasing revenue dependence on U.S. business as the contract research and manufacturing organization navigates investor concern about alleged ties to Chinese military programs. Management acknowledged the growing U.S. contribution to sales while the firm continues to face geopolitical scrutiny that could affect client relationships and regulatory interactions. The company reiterated its global service model but noted that revenue diversification is now more U.S.‑centric, a strategic shift that may insulate parts of the business from Chinese market volatility. Analysts flagged the risk that ongoing geopolitical questions could slow partnerships or contracts in certain segments. WuXi’s update underscores how geopolitics and national‑security concerns are reshaping vendor selection, investment flows, and outsourcing strategies across the life‑sciences supply chain.